Brief Report: Rituximab for the Treatment of Adult ‐Onset IgA Vasculitis (Henoch‐Schönlein)

ConclusionOur data suggest that RTX is an effective and safe therapeutic option for adult‐onset IgAV.

Source: Arthritis and Rheumatism - December 1, 2017 Category: Rheumatology Authors: Federica Maritati, Roberta Fenoglio, Evangeline Pillebout, Giacomo Emmi, Maria L. Urban, Rossana Rocco, Maria Nicastro, Monia Incerti, Matteo Goldoni, Giorgio Trivioli, Elena Silvestri, Aladdin J. Mohammad, David Jayne, Per Eriksson, M årten Segelmark, P Tags: Brief Report Source Type: research